Evolent Health

Quarterly Financials

Values in thousands2026-03-312025-12-312025-09-302025-06-30
Revenue
$496,246
$468,719
$479,533
$444,328
Gross Profit
61,919
52,216
75,859
76,944
EBITDA
12,349
35,397
27,454
27,253
EBIT
-10,137
-9,640
658
2,826
Net Income
-26,632
-429,131
-20,864
-19,897
Net Change In Cash
496,246
468,719
479,533
444,328
Free Cash Flow
-7,390
41,039
6,850
-39,104
Cash
166,005
151,856
116,650
150,995
Basic Shares
111,905
114,208
114,066
115,882

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$1,876,229
$2,554,741
$1,963,896
$1,352,013
Gross Profit
284,032
367,353
460,470
316,584
EBITDA
111,416
84,854
-24,785
43,746
EBIT
-4,435
-38,314
-148,200
-46,505
Net Income
-534,510
-61,623
-113,040
-19,164
Net Change In Cash
1,876,229
2,554,741
1,963,896
1,352,013
Cost of Revenue
-139,127
Free Cash Flow
4,755
-6,128
113,837
-49,914
Cash
151,856
104,203
192,825
188,200
Basic Shares
114,208
114,682
111,251
93,699

Earnings Calls

QuarterEPS
2026-03-31
-$0.02
2025-12-31
$0.08
2025-09-30
$0.05
2025-06-30
-$0.10